Ascendis Pharma A/S (BVMF:A1SN34)
Brazil flag Brazil · Delayed Price · Currency is BRL
70.21
-1.26 (-1.76%)
At close: Nov 4, 2025

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 213.63M EUR in the quarter ending September 30, 2025, with 269.40% growth. This brings the company's revenue in the last twelve months to 646.55M, up 97.46% year-over-year. In the year 2024, Ascendis Pharma had annual revenue of 363.64M with 36.34% growth.

Revenue (ttm)
646.55M EUR
Revenue Growth
+97.46%
P/S Ratio
16.80
Revenue / Employee
635.74K EUR
Employees
1,017
Market Cap
67.94B BRL

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024363.64M96.92M36.34%
Dec 31, 2023266.72M215.54M421.20%
Jan 1, 202351.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 20206.95M-6.42M-48.01%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rede D'Or São Luiz 54.20B
Raia Drogasil 42.23B
Hypera 6.97B
Fleury 8.07B
Odontoprev 2.53B
Diagnósticos da América 12.57B
Empreendimentos Pague Menos 14.27B
Blau Farmacêutica 1.77B
Revenue Rankings